Brief: Taro posts Q2 sales USD 148.202 million
Oct 26 (Reuters) - Taro Q2 net income USD 8.547 million. * Q2 sales USD 148.202 million * Q2 gross profit USD 73.602 million * Q2 operating income USD 4.74 million
Recent news on Taro Pharmaceutical Industries
See all newsBrief: Taro Pharmaceutical Industries Says Taro Shareholders Approve Merger With Sun Pharma
Taro Pharmaceutical Industries Ltd reports results for the quarter ended in March - Earnings Summary
Taro Pharmaceutical Industries Ltd expected to post earnings of 31 cents a share - Earnings Preview
Ex-Sandoz exec gets probation for price-fixing after cooperation deal
Brief: ISS, Glass Lewis Recommend Taro Shareholders Vote For Merger With Sun Pharma